1160682-52-9

Upstream product

• 84832-01-9 methyl 2,6-difluoro-3-nitrobenzoate 
• 346691-23-4 methyl 2-amino-6-fluoro-3-nitrobenzoate 
• 13671-00-6 methyl 2,6-difluorobenzoate 

Downstream Products

• 1160685-96-0 methyl 7-bromo-6-(methyloxy)-2-oxo-3-phenyl-1,2-dihydro-5-quinoxalinecarboxylate 
• 1160682-79-0 Methyl 7-bromo-3-(3,4-difluorophenyl)-6-(methyloxy)-5-quinoxalinecarboxylate 
• 1160682-64-3 Methyl 2-amino-5-(1-methylethenyl)-6-(methyloxy)-3-nitrobenzoate 
• 1160682-83-6 Methyl 7-bromo-3-(2,4-difluorophenyl)-6-(methyloxy)-5-quinoxalinecarboxylate 
• 1160682-75-6 methyl 2,3-diamino-5-bromo-6-(methyloxy)benzoate 
• 1160683-94-2 N-({3-(3,4-difluorophenyl)-7-[4-(1,1-dimethylethyl)phenyl]-6-hydroxy-5-quinoxalinyl}carbonyl)glycine 
• 1160683-97-5 N-[(3-(3,4-difluorophenyl)-6-hydroxy-7-{3-[(1-methylethyl)oxy]phenyl}-5-quinoxalinyl)carbonyl]glycine 
• 1160683-98-6 N-[(3-(3,4-difluorophenyl)-6-hydroxy-7-{4-[(1-methylethyl)oxy]phenyl}-5-quinoxalinyl)carbonyl]glycine 
• 1160683-67-9 N-{[7-(1-cyclohexen-1-yl)-3-(3,4-difluorophenyl)-6-hydroxy-5-quinoxalinyl]carbonyl}glycine 
• 1160683-77-1 N-{[7-cyclohexyl-3-(3,4-difluorophenyl)-6-hydroxy-5-quinoxalinyl]carbonyl}glycine 
• 1160685-66-4 ethyl N-{[2-(3,4-difluorophenyl)-7-(3-fluorophenyl)-6-hydroxy-5-quinoxalinyl]carbonyl}glycinate 
• 1160683-99-7 N-{[3-(3,4-difluorophenyl)-7-(3-fluorophenyl)-6-hydroxy-5-quinoxalinyl]carbonyl}glycine 
• 1160685-61-9 N-{[2-(3,4-difluorophenyl)-7-(3-fluorophenyl)-6-hydroxy-5-quinoxalinyl]carbonyl}glycine 
• 1160683-45-3 ethyl N-({6-hydroxy-7-[1-(phenylsulfonyl)-1H-indol-3-yl]-5-quinoxalinyl}carbonyl)glycinate 

Relevant academic research and scientific papers

Prolyl Hydroxylase Inhibitors

The invention described herein relates to certain quinoxaline-5-carboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.

PROLYL HYDROXYLASE INHIBITORS

The invention described herein relates to certain benzimidazol-4-ylcarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one